Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04091750
Title Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

melanoma

Therapies

Cabozantinib + Ipilimumab + Nivolumab

Cabozantinib + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center Recruiting Washington District of Columbia 20007 United States Details
Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute Recruiting Baltimore Maryland 21237 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field